234 related articles for article (PubMed ID: 28238453)
1. Vitiligo and overt thyroid diseases: A nationwide population-based study in Korea.
Bae JM; Lee JH; Yun JS; Han B; Han TY
J Am Acad Dermatol; 2017 May; 76(5):871-878. PubMed ID: 28238453
[TBL] [Abstract][Full Text] [Related]
2. Alopecia areata and overt thyroid diseases: A nationwide population-based study.
Han TY; Lee JH; Noh TK; Choi MW; Yun JS; Lee KH; Bae JM
J Dermatol; 2018 Dec; 45(12):1411-1417. PubMed ID: 30222206
[TBL] [Abstract][Full Text] [Related]
3. Comorbid autoimmune diseases in patients with vitiligo: A cross-sectional study.
Gill L; Zarbo A; Isedeh P; Jacobsen G; Lim HW; Hamzavi I
J Am Acad Dermatol; 2016 Feb; 74(2):295-302. PubMed ID: 26518171
[TBL] [Abstract][Full Text] [Related]
4. Association Between Eight Autoimmune Diseases and Thyroid Cancer: A Nationwide Cohort Study.
Park SK; Ryoo JH; Kim MH; Jung JY; Jung YS; Kim KN; Shin S; Oh CM
Thyroid; 2024 Feb; 34(2):206-214. PubMed ID: 38149584
[No Abstract] [Full Text] [Related]
5. Prevalence of vitiligo and associated comorbidities in Korea.
Lee H; Lee MH; Lee DY; Kang HY; Kim KH; Choi GS; Shin J; Lee HJ; Kim DH; Kim TH; Lee AY; Lee SC; Lee S; Kim KW; Hann SK; Park CJ; Oh SH
Yonsei Med J; 2015 May; 56(3):719-25. PubMed ID: 25837178
[TBL] [Abstract][Full Text] [Related]
6. The Prevalence of Thyroid Disorders in Patients With Vitiligo: A Systematic Review and Meta-Analysis.
Yuan J; Sun C; Jiang S; Lu Y; Zhang Y; Gao XH; Wu Y; Chen HD
Front Endocrinol (Lausanne); 2018; 9():803. PubMed ID: 30697190
[No Abstract] [Full Text] [Related]
7. Increased risk for incident thyroid diseases in people with psoriatic disease: A cohort study.
Wang SH; Wang J; Lin YS; Tung TH; Chi CC
J Am Acad Dermatol; 2019 Apr; 80(4):1006-1012. PubMed ID: 30528501
[TBL] [Abstract][Full Text] [Related]
8. Bidirectional association between alopecia areata and thyroid diseases: a nationwide population-based cohort study.
Dai YX; Tai YH; Chang YT; Chen TJ; Chen MH
Arch Dermatol Res; 2021 Jul; 313(5):339-346. PubMed ID: 32705333
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of malignant tumors and adenomatous lesions detected by ultrasonographic screening in patients with autoimmune thyroid diseases.
Mukasa K; Noh JY; Kunii Y; Matsumoto M; Sato S; Yasuda S; Suzuki M; Ito K; Ito K
Thyroid; 2011 Jan; 21(1):37-41. PubMed ID: 20932180
[TBL] [Abstract][Full Text] [Related]
10. Comorbidity profiles in association with vitiligo: a nationwide population-based study in Taiwan.
Chen YT; Chen YJ; Hwang CY; Lin MW; Chen TJ; Chen CC; Chu SY; Lee DD; Chang YT; Liu HN
J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1362-9. PubMed ID: 25510261
[TBL] [Abstract][Full Text] [Related]
11. Increased risk of thyroid diseases in patients with systemic lupus erythematosus: A nationwide population-based Study in Korea.
Yun JS; Bae JM; Kim KJ; Jung YS; Kim GM; Kim HR; Lee JS; Ko SH; Cha SA; Ahn YB
PLoS One; 2017; 12(6):e0179088. PubMed ID: 28654679
[TBL] [Abstract][Full Text] [Related]
12. [Autoimmune thyroid disease. Clinical and biological correlations].
El Hajj G; Yahya AF; Medlej R; Sebaaly G; Souaid M; Halaby G
J Med Liban; 2009; 57(4):218-25. PubMed ID: 20027797
[TBL] [Abstract][Full Text] [Related]
13. Vitiligo and thyroid dysfunction in children and adolescents.
Prćić S; Djuran V; Katanić D; Vlaški J; Gajinov Z
Acta Dermatovenerol Croat; 2011; 19(4):248-54. PubMed ID: 22185925
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B vaccine and risk of autoimmune thyroid disease: a Vaccine Safety Datalink study.
Yu O; Bohlke K; Hanson CA; Delaney K; Rees TG; Zavitkovsky A; Ray P; Mullooly J; Black SB; Benson P; Thompson WW; Davis RL; Jackson LA
Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):736-45. PubMed ID: 17192842
[TBL] [Abstract][Full Text] [Related]
15. Hashimoto Thyroiditis, Anti-Parietal Cell Antibodies: Associations With Autoimmune Diseases and Malignancies.
Boutzios G; Koukoulioti E; Goules AV; Kalliakmanis I; Giovannopoulos I; Vlachoyiannopoulos P; Moutsopoulos HM; Tzioufas AG
Front Endocrinol (Lausanne); 2022; 13():860880. PubMed ID: 35528009
[TBL] [Abstract][Full Text] [Related]
16. Increased prevalence of chronic autoimmune (Hashimoto's) thyroiditis in children and adolescents with vitiligo.
Kakourou T; Kanaka-Gantenbein C; Papadopoulou A; Kaloumenou E; Chrousos GP
J Am Acad Dermatol; 2005 Aug; 53(2):220-3. PubMed ID: 16021113
[TBL] [Abstract][Full Text] [Related]
17. Markedly Reduced Risk of Internal Malignancies in Patients With Vitiligo: A Nationwide Population-Based Cohort Study.
Bae JM; Chung KY; Yun SJ; Kim H; Park BC; Kim JS; Seo SH; Ahn HH; Lee DY; Kim YC; Park HJ; Kim M
J Clin Oncol; 2019 Apr; 37(11):903-911. PubMed ID: 30785828
[TBL] [Abstract][Full Text] [Related]
18. Vitiligo epidemiological profile and the association with thyroid disease.
Nunes DH; Esser LM
An Bras Dermatol; 2011; 86(2):241-8. PubMed ID: 21603806
[TBL] [Abstract][Full Text] [Related]
19. Concomitant Thyroid Disorders and Inflammatory Bowel Disease: A Literature Review.
Shizuma T
Biomed Res Int; 2016; 2016():5187061. PubMed ID: 27042663
[TBL] [Abstract][Full Text] [Related]
20. Increased risk of comorbid rheumatic disorders in vitiligo patients: A nationwide population-based study.
Choi CW; Eun SH; Choi KH; Bae JM
J Dermatol; 2017 Aug; 44(8):909-913. PubMed ID: 28370282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]